Can this Israeli coronavirus drug 'completely prevent' lung damage?
Bonus BioGroup has completed a preliminary study of a new drug to treat acute and life-threatening respiratory distress in COVID-19 patients.
MesenCure development entrepreneurs (from right): Dr. Dror Ben David, Dr. Shai Meretzky and Tomer Bronstein